We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




RPM Platform Helps Manage Gestational Diabetes

By HospiMedica International staff writers
Posted on 14 Sep 2021
A cellular-connected blood glucose remote patient monitoring (RPM) device provides simplified and improved patient care and support during pregnancy.

The Smart Meter (Tamps, FL, USA) iGlucose Blood Glucose Monitoring (BGM) system is an out-of-the-box ready device for patients of all ages that provides reliable and immediate cellular transmission of blood glucose readings via the proprietary AutoShare feature, thereby eliminating the need for logbooks, faxes, and avoidable phone calls. More...
In addition, Autoshare eliminates complicated Bluetooth pairing, syncing, and uploading by providing a seamless cellular connectivity experience.

Results can be viewed immediately by care providers, who can react in real-time to adjust diet or medication, potentially reducing care costs and trips to the hospital. The BGM is accompanied by the iGlucose virtual coach, which communicates with the user via text and email messages, reminders and alerts, notification of blood glucose results, and messages sent to engage the user’s circle of care. In addition, BGM includes the iGlucose personal web portal, which automatically generates logbook and reports.

“We've seen great success with our iGlucose monitors in other markets, such as long-term care (LTC), and we're thrilled to now offer our solution to support women with gestational diabetes,” said Casey Pittock, CEO of Smart Meter. “Pregnancy can be a stressful time. iGlucose can help provide peace of mind that patients are getting the best care and support possible.”

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The definition applies whether insulin or only diet modification is used for treatment, and whether or not the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy. About 7% of all pregnancies are complicated by GDM, with a prevalence of 1-14% of all pregnancies, depending on the population studied and the diagnostic tests employed.

Related Links:
Smart Meter


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Open Stapler
PROXIMATE Linear Cutter
New
3-Channel ECG Event Recorder
ECG Time S
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.